查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美快速檢測試劑盒市場預測至 2030 年 - 區域分析 - 按類型、產品、技術、應用和最終用戶
市場調查報告書
商品編碼
1562199

北美快速檢測試劑盒市場預測至 2030 年 - 區域分析 - 按類型、產品、技術、應用和最終用戶

North America Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 157 Pages | 訂單完成後即時交付

價格

2022年北美快速檢測試劑盒市值為68.694億美元，預計到2030年將達到104.6282億美元；預計2022年至2030年複合年成長率為5.4%。

遺傳性疾病和傳染病患者病率的上升推動了北美快速檢測試劑盒市場

MJH Life Sciences（美國）2022 年的報告估計，全球每年有 30 萬名新生兒出生時患有鐮狀細胞疾病。根據疾病預防控制中心 (CDC) 的數據，每 500 名非裔美國人中就有 1 人患有鐮狀細胞疾病。世界衛生組織 (WHO) 最新發布的《2022 年世界瘧疾報告 (WMR)》指出，2021 年全球報告了近 2.47 億例新發瘧疾病例，而 2020 年記錄的病例為 2.45 億例。造成的死亡人數為61.9萬人。

Sickle SCAN 是一種快速檢測鐮狀細胞性貧血的方法，具有高靈敏度和特異性。快速診斷測試 (RDT) 透過檢測人體血液中是否存在瘧疾寄生蟲來幫助診斷瘧疾。在獲得高品質顯微鏡服務的機會有限的情況下，放射診斷技術被用作臨床或基於顯微鏡的診斷的替代方法。 COVID-19 大流行對快速檢測試劑盒市場產生了重大影響。幾乎所有診斷測試都使用即時 PCR 來測試表現出 SARS-CoV-2 感染症狀的人。快速檢測試劑盒幾乎無所不在、強大且可靠。大多數分子生物學實驗室都使用快速測試技術，包括擴增特定 DNA 片段以進行基因分型、克隆和單核苷酸變異分析。因此，遺傳性疾病和傳染病發病率的增加推動了快速檢測試劑盒市場的成長。

北美快速檢測試劑盒市場概況

CRISPR 和 PCR 等基因合成和編輯工具在研究和治療中的快速採用需要有助於快速定量、改變和觀察的檢測方法。美國正在向公共和私人組織尋求大量資金，預計將在先進研究方法上進行大量投資，並預計在快速檢測試劑盒市場中處於領先地位。在 SARS-CoV-2 Delta 流行期間和 Omicron 流行期間，家庭測試的使用量迅速增加。據 CDC 稱，2023 年 4 月，美國各地運送了超過 7,000 萬份檢測試劑盒。

北美快速檢測試劑盒市場收入及 2030 年預測（百萬美元）

北美快速檢測試劑盒市場細分

北美快速檢測試劑盒市場根據類型、產品、技術、應用、最終用戶和國家進行細分。根據類型，北美快速檢測試劑盒市場分為快速抗原檢測、快速抗體檢測等。 2022 年，快速抗原檢測領域佔據最大的市場。

從產品來看，北美快速檢測試劑盒市場分為非處方快速檢測試劑盒和專業快速檢測試劑盒。非處方快速檢測試劑盒細分市場在 2022 年佔據更大的市場。

依技術分類，北美快速檢測試劑盒市場分為側流檢測、固相檢測、凝集檢測、免疫斑點檢測和基於細胞成分的檢測。 2022 年，側流分析領域佔據最大的市場佔有率。

根據應用，北美快速檢測試劑盒市場分為血糖檢測、傳染病檢測、懷孕及生育、心臟代謝檢測等。 2022年，血糖檢測領域佔據最大的市場佔有率。

就最終用戶而言，北美快速檢測試劑盒市場分為醫院和診所、家庭護理、診斷中心等。 2022 年，醫院和診所領域佔據最大的市場。

根據國家/地區，北美快速檢測試劑盒市場分為美國、加拿大和墨西哥。 2022年，美國在北美快速檢測試劑盒市場佔有率中佔據主導地位。

F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、廣州萬孚生物科技有限公司、Denka Co Ltd、 Abbott Laboratories 、Trinity Biotech Plc、SD Biosensor Inc、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是北美快速檢測試劑盒市場的一些領先參與者。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美快速測試套件市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
    • 製造商的策略舉措
  • 市場限制
    • 與結果準確性相關的不確定性
  • 市場機會
    • 對 PCR 技術的偏好不斷增加
  • 未來趨勢
    • 快速抗原檢測的創新
  • 影響分析

第 5 章：快速測試套件市場 - 北美市場分析

  • 概述
  • 快速測試套件市場收入，2020 - 2030

第 6 章：北美快速檢測試劑盒市場分析 - 按類型

  • 概述
  • 快速抗原檢測
  • 快速抗體檢測
  • 其他

第 7 章：北美快速檢測試劑盒市場分析 - 按產品

  • 概述
  • 非處方快速檢測試劑盒
  • 專業快速檢測試劑盒

第 8 章：北美快速檢測試劑盒市場分析 - 按技術

  • 概述
  • 側流層析
  • 固相
  • 凝集
  • 免疫斑點測定
  • 基於蜂窩組件

第 9 章：北美快速檢測試劑盒市場分析 - 按應用

  • 概述
  • 血糖測試
  • 傳染病檢測
  • 心臟代謝測試
  • 懷孕和生育
  • 其他

第 10 章：北美快速測試套件市場分析 - 按最終用戶

  • 概述
  • 醫院和診所
  • 診斷中心
  • 居家護理
  • 其他

第 11 章：北美快速檢測試劑盒市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 12 章：產業格局

  • 概述
  • 快速檢測試劑盒市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 13 章：公司簡介

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • SD Biosensor Inc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Beckman Coulter Inc

第 14 章：附錄

Product Code: BMIRE00030521

The North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Fuels North America Rapid Test Kit Market

A 2022 report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year. According to the CDC, 1 in 500 African Americans is affected by sickle cell disease. The latest World Malaria Report (WMR) 2022 from the World Health Organization (WHO) states that nearly 247 million new malaria cases were reported in the world in 2021, in comparison to 245 million cases that were logged in 2020. According to the same source, the number of deaths caused due to malaria was 619,000 in 2021.

Sickle SCAN is a rapid test for the identification of sickle cell anemia with high sensitivity and specificity. Rapid diagnostic tests (RDTs) help diagnose malaria by detecting the presence of malarial parasites in human blood. Where access to high-quality microscopy services is limited, radiological diagnosis techniques are used as an alternative for clinical or microscope-based diagnosis. The COVID-19 pandemic had a significant impact on the rapid test kits market. Nearly all diagnostic tests used real-time PCR for testing people who showed symptoms of SARS-CoV-2 infection. Rapid test kits are nearly ubiquitous, robust, and reliable. Rapid testing techniques that involve the amplification of specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis are used in most molecular biology labs. Thus, the increasing incidence of genetic and infectious diseases propels the growth of the rapid test kits market.

North America Rapid Test Kit Market Overview

The rapid adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that are helpful in terms of rapid quantification, alterations, and observation. The US, seeking significant funding from public and private organizations, is expected to invest significantly in advanced research methodologies and is expected to be in the leading position in the rapid test kits market. There was a rapid increase in at-home test use occurred between the SARS-CoV-2 Delta- and Omicron-predominant periods of the pandemic. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US.

North America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

North America Rapid Test Kit Market Segmentation

The North America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the North America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the North America rapid test kit market is segmented into the US, Canada, and Mexico. The US dominated the North America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the North America rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. North America Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Rapid Test Kits Market - Country Analysis

  • 11.1 North America: Rapid Test Kits Market
    • 11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 United States
        • 11.1.1.1.1 Overview
      • 11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Overview
      • 11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
      • 11.1.1.6 Mexico
        • 11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Fujirebio Europe NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 bioMerieux SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cepheid
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Meril Life Sciences Pvt Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 QIAGEN NV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 OraSure Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Guangzhou Wondfo Biotech Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Denka Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Abbott Laboratories
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Trinity Biotech Plc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 SD Biosensor Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Beckman Coulter Inc
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Growth Strategies in the Rapid Test Kit Market